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352a Monday, February 27, 2012ratio of myosin heavy chain (MyHC) isoforms, a- and b-MyHC, expressed in
the ventricles. Normal human ventricles express ~10% of the fast a-MyHC
on a background of the slower b-MyHC, while in failing hearts a-MyHC is re-
duced to virtually undetectable levels with complete replacement by b-MyHC.
Data from permeabilized myocardial preparations suggests that this isoform
switch may be partly responsible for reduced myocardial twitch force and pres-
sure development by failing ventricles since b-MyHC is a slower motor protein,
yet most experiments have used non-human myosins and experimental condi-
tions in which preparations were steadily activated, thus little is known about
the response of human myosins to a time-varying Ca2þ transient. To address
these limitations, we recently developed a human 3D engineered cardiac tissue
(hECT) system in which we can express recombinant human muscle myosin
motors. Using commercially available cloning and adenoviral expression sys-
tems, a- or b-MyHC isoform expressing adenoviral particles were used to trans-
duce human cardiomyocytes produced from human iPS cells and construct
hECTs. Preparations displayed well-defined cellular structure with elongated
morphology aligned in the direction of preparation shortening during electrical
pacing, while histological analysis of hECT revealed appropriate protein ex-
pression and localization within the sarcomere. In response to a Ca2þ transient,
the time-course of twitch force development was accelerated in hECT express-
ing a-MyHC compared to b-MyHC, while peak twitch force was greater in
hECT expressing a-MyHC. These results demonstrate the relative contribution
of myosin isoforms to myocardial twitch kinetics in human engineered cardiac
tissue constructs expressing a stable background of myofibrillar proteins.
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Current laboratory methods used to assess neonatal and adult cardiocyte func-
tion include measurement of gene and protein expression levels, calcium tran-
sients, and contractility. Our goal was to develop simple tools to analyze such
data readily. We created two MATLAB-based toolboxes; the Contraction
Video Processing (CVP) and the Cardiocyte Functional Response Analysis
(CFRA) Toolbox. Videos of contracting cultured cardiocytes are acquired us-
ing a digital camera attached to an inverted phase microscope. Video frames
are analyzed using digital imaging processing techniques along with several
contraction assessment methods available through the CVP toolbox. The
CVP offers direct correlation, pixel intensity tracking and Polar Fourier trans-
form methods for the analysis of neonatal cardiocyte contraction. Analysis of
adult cardiocytes includes those implemented on neonatal cardiocytes in addi-
tion to area boundary tracking, Fourier descriptor analysis, and cell length
tracking methods. The resulting contraction records are processed using the
CFRA toolbox to provide quantitative analyses of cardiocyte contractility
and calcium transient responses. Transient data are obtained by measuring
the calcium fluxes using the fluorescent dye Fluo-3, and a Photon Technology
fluorometer system running Felix software. Data analysis routines have been
created and tailored exclusively to the characteristics and needs of cellular car-
diovascular research investigators. The analytical methods created are used to
find the onset of contraction, perform signal averaging, and acquire statistical
information of functional data. CFRA toolbox contractility processing yields
onset time, time-to-peak, duration, and fast and slow recovery times. CFRA
toolbox calcium transient signal processing yields onset time, signal intensity,
and fast and slow exponential recovery rates associated with SERCA and NCX
channels respectively. The toolboxes allow examination of beat-to-beat con-
tractility and calcium transient variations within the same cardiocyte as well
as from cell population to population. Supported by NIH/NIGMS SDSU
MARC Program 5T34GM008303-22
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Cardiac hypertrophy is associated with Diastolic Heart Failure (DHF), a syn-
drome in which systolic function is preserved, but cardiac filling dynamics
are depressed. The molecular mechanisms underlying DHF and the potential
role of altered cross-bridge cycling in this syndrome are poorly understood.
Accordingly, we induced chronic pressure overload by surgically banding the
thoracic ascending aorta in female Dunkin Hartley Guinea pigs weighing
400g, for 12-16 weeks. Guinea pigs were chosen to avoid the confounding ef-
fects of myosin isoform switch that occurs in other small rodent models. Left
ventricular (LV) samples were frozen in liquid N2. Aortic banding resulted
in (þ31%) LV hypertrophy (LV/BW ratio) and reduced diastolic cardiac
function, but normal systolic function. Single myofibrils were prepared by me-chanical dissociation and subsequently attached between two glass micro-
needles that were positioned on the stage of an inverted phase-contrast micro-
scope. While the maximum calcium saturated force development was de-
pressed (18%), the time required for force relaxation was increased (þ8%)
in parallel to a significant decrease in the rate of relaxation (25%) in DHF
myofibrils; Myosin Heavy Chain (MHC) isoform distribution was unaltered.
We conclude that slower cross-bridge relaxation kinetics contribute to diastolic
dysfunction in cardiac hypertrophy.
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Heart failure is a progressive condition in which the ventricles can no longer
pump enough blood to meet the body’s basal demands. Our laboratory is inves-
tigating whether the transmural variation in cellular contractile properties that
occurs in normal hearts (and which is thought to be important for ventricular
function) is altered in heart failure. We procured through wall samples of fail-
ing left ventricle from patients receiving transplants at the University of
Kentucky and non-failing samples from brain dead organ donors. The tissue
was divided into epicardial, midmyocardial and endocardial layers and frozen
in liquid nitrogen within 30 minutes. Multicellular chemically permeabilized
preparations were subsequently obtained from these samples by mechanical ho-
mogenization and triton treatment. The samples were attached between a force
transducer and a motor and subjected to two mechanical protocols: 1) a stretch-
restretch protocol in solutions with different activating Ca2þ concentrations
and 2) a force-velocity protocol in which maximally-activated preparations
were allowed to shorten against pre-set loads. Parameters including steady-
state force, short-range stiffness, short-range force and maximum power output
were measured using these two protocols. The results suggested a 30% decrease
in maximum power output (p-value = 0.01) and steady-state force (p-
value=0.005) in heart failure patients (n=8, total of 72 preparations) as
compared to non-failing (n=4, total of 36 preparations). Short-range stiffness
(p-value=0.003) and short-range force (p-value=0.002) also significantly de-
creased in heart failure vs. non-failing. Transmurally there was a significant dif-
ference in maximum power output between the regions (p-value=0.02). The
data suggests that mechanically the mid myocardium maybe affected the
most in heart failure. Further studies need to be done to understand the protein
modifications that may be responsible for these variations.
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Pulmonary artery hypertension (PAH) can cause right ventricular (RV) con-
tractile dysfunction and failure by mechanisms that are not fully understood.
PAH and RV failure were induced in male Wistar rats (200g) 3-4 weeks after
a single injection of 60 mg/kg monocrotaline (MCT). Single RV myocytes
were isolated from extracted hearts and fast Fourier transform of their video im-
age was used to compare resting sarcomere lengths (SL) of myocytes from
MCT and saline injected control animals (CON) during superfusion with
a physiological saline solution.
There was no difference in resting intracellular Ca2þ levels in cells loaded
with the Ca2þ-indicator Fura-4 (MCT 0.31 5 0.02 ratio units n= 10 cells;
CON, 0.305 0.01 ratio units n= 11 cells, P > 0.05, unpaired t-test). However,
resting SL was significantly shorter in MCT myocytes (1.785 0.01 mm) than
CON (1.905 0.01 mm) P < 0.001. When Ca2þ-dependant cross-bridges were
inhibited by exposure to the Ca2þ buffer BAPTA-AM (100 mM for 10 min) SL
increased in both groups by similar amounts (MCT 0.015 0.003 mm vs CON
0.03 5 0.01 mm, P > 0.05). Inhibition of Ca2þ-independent cross-bridges by
exposure to BAPTA plus the actin-myosin inhibitor BDM (40 mM for
5 min) further increased SL, this effect was significantly greater in MCT
